Cebeni Nkosihawukile Langa

Ms. Cebeni Nkosihawukile Langa

Biomanufacturing Technologies, Council for Scientific and Industrial Research, Pretoria, Gauteng, South Africa

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
YRYrielle Roets-Dlamini
Yrielle Roets-Dlamini
CLCebeni Nkosihawukile Langa
Cebeni Nkosihawukile Langa
SRSantosh Ramchuran
Santosh Ramchuran
The use of probiotics has been gaining popularity in terms of inclusion into human diets over recent years. Based on properties exerted by these organisms, several benefits have been elucidated and conferred to the host. Bacteria have been more commonly used in probiotic preparations compared to yeast candidates; however, yeast exhibit several beneficial properties, such as the prevention and treatment of diarrhea, the production of antimicrobial agents, the prevention of pathogen adherence to intestinal sites, the maintenance of microbial balance, the modulation of the immune system, antibiotic resistance, amongst others. Saccharomyces boulardii is by far the most studied strain; however, the potential for the use of other yeast candidates, such as Kluyveromyces lactis and Debaryomyces hansenii, amongst others, have also been evaluated in this review. Furthermore, a special focus has been made regarding the production considerations for yeast-based probiotics and their formulation into different delivery formats. When drafting this review, evidence suggests that the use of yeasts, both wild-type and genetically modified candidates, can extend beyond gut health to support skin, the respiratory system, and overall immune health. Hence, this review explores the potential of yeast probiotics as a safe, effective strategy for preventative health in humans, highlighting their mechanisms of action, clinical applications, and production considerations.

1 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
YRYrielle Roets-Dlamini
Yrielle Roets-Dlamini
CLCebeni Nkosihawukile Langa
Cebeni Nkosihawukile Langa
SRSantosh Ramchuran
Santosh Ramchuran
The use of probiotics has been gaining popularity in terms of inclusion into human diets over recent years. Based on properties exerted by these living organisms, several benefits have been elucidated and conferred to the host. Bacteria has been more commonly used in probiotic preparations, in comparison to yeast candidates, however, yeast exhibit several beneficial properties such as the prevention and treatment of diarrhoea, production of antimicrobial agents, prevention of pathogen adherence to intestinal sites, maintain microbial balance, modulation of the immune system, resistant to some antibiotics, amongst others. This review details the use of yeast organisms as biotherapeutics and has a special focus on production considerations and their formulation into different delivery formats.